EUVIMED · CrossrefZeitschrift
Haematologica
ISSN 0390-6078 · Ferrata Storti Foundation (Haematologica)
Neueste Artikel
Onset-subtype-dependent diagnostic performance of serum hyaluronic acid for sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation
Intercellular transfer of FOLR2 from nurse-like cells fuels chronic lymphocytic leukemia cell activation and proliferation
Clonal hematopoiesis in long-term survivors after allogeneic hematopoietic cell transplantation: associations with active chronic graft-versus-host disease, donor age, and transplantation for chronic myeloid leukemia
Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome
Transcriptional landscape of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma: tumor microenvironment and checkpoint genes
Rapid identification of the high-risk IGLV3-21R110 subgroup of chronic lymphocytic leukemia by flow cytometry
ICOS/ICOSL coexpression in Sézary syndrome reveals a potential tumorpromoting T-cell interaction
Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia
Paraneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia
Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis
Response to comment on: “Immune checkpoint therapy in pediatric and adolescent lymphomas”.
Response to Comment on: “Risk factors and their contributions to prognosis in multiple myeloma”
Response to Comment on: “Avatrombopag as a novel salvage therapy for refractory thrombocytopenia in THPO-mutated congenital amegakaryocytic thrombocytopenia after allogeneic hematopoietic stem cell transplantation”
Blasting high-burden T-large granular lymphocytic leukemia with bendamustine
Monoclonal gammopathy-related thrombocytopenia. Comment on: “Diagnostic and therapeutic challenges in rare hematologic entities: monoclonal gammopathy of thrombotic and bleeding significance”
Functional DNase assessment in posttransplant lung injury. Comment on: "Neutrophil extracellular traps and DNase I levels in the bronchoalveolar lavage fluid of children with pulmonary injury after allogeneic hematopoietic stem cell transplantation: a TRANSPIRE study"
Response to Comment on: “Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism”
Prospective study of longitudinal geriatric assessment with risk-adapted interventions for older patients in allogeneic hematopoietic cell transplantation
Distinct clinical and molecular profiles of acute myeloid leukemia defined by mutations in IDH1, IDH2, and TET2
Platelet and megakaryocyte function in the pathogenesis of POEMS syndrome
CD34+-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a large cohort study focusing on haploidentical transplantation
BCL11B-activated pediatric acute myeloid leukemia: a high-risk disease with frequent induction failure
Frontline isocitrate dehydrogenase inhibitor therapy in isocitrate dehydrogenasemutated myelodysplastic neoplasms
Flow cytometric detection of the thymic stromal lymphopoietin receptor reliably identifies CRLF2-rearranged BCR::ABL1-like acute lymphoblastic leukemia
Salvage-free, transplantation-free survival: a proposal for a new clinical endpoint in acute myeloid leukemia
Quantitative CD19 expression in pediatric NUP98-rearranged myeloid neoplasms: enrichment at relapse or progression and in the NUP98::NSD1 subtype
Frequent FLT3 and IDH co-mutations in acute myeloid leukemia with mutated NPM1, NUP98 rearrangement, and KMT2A partial tandem duplication but not rearrangement: potential for combined targeted therapy
Depletion of CD19-positive B-cells and dexamethasone premedication may result in immune suppression in patients with B-precursor acute lymphoblastic leukemia after consolidation treatment with blinatumomab
Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed products
Association does not establish causation. Comment on: “Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopenia”
EUVIMED